baber/WOPTO huggingface dataset:
Patent DE-69313534-D1 (DE)
Inventor: MELLONI PIERO
IPC: A61P9/00
Filed: 1993-06-16
Granted: 1997-10-09
Abstract: Digitoxigenin and dihydrodigitoxigenin 3 beta -derivatives, a process for their preparation and pharmaceutical compositions containing same for the treatment of cardiovascular disorders such as heart failure and hypertension are disclosed.
Patent DE-69317705-D1 (DE)
Inventor: VAN SEVEREN BERNARD
IPC: B65H55/00
Filed: 1993-06-24
Granted: 1998-05-07
Abstract: A spool (10) is filled with an elongated metal element (12) which is wound onto the spool with a plurality of windings. The plurality of windings end with a final winding (22) and n windings (24) preceding the final winding ("n preceding windings"), n is hereby greater than or equal to one. The final winding (22) comprises a beginning part (26), a middle part (28) and a trailing end (20). The middle part (28) is under the n preceding windings (24) in order to secure the final winding to the rest of the elongated element. The beginning part (26) and the trailing end (20) are at the same side of the n preceding windings (24).
Patent DE-69326351-D1 (DE)
Inventor: MYNOTT TRACEY LEAHANNE
IPC: A61K38/46
Filed: 1993-06-30
Granted: 1999-10-14
Abstract: PCT No. PCT/GB93/01374 Sec. 371 Date Feb. 14, 1995 Sec. 102(e) Date Feb. 14, 1995 PCT Filed Jun. 30, 1993 PCT Pub. No. WO94/00147 PCT Pub. Date Jan. 6, 1994Enzymes, especially proteolytic enzymes such as bromelain, have been found to inhibit the action of heat-labile toxin (LT) of enterotoxigenic Escherichia coli. They are therefore useful in the prophylaxis, management and treatment of diarrhoea in humans.
Patent DE-69326450-D1 (DE)
Inventor: CHERPECK RICHARD
IPC: C10L1/192
Filed: 1993-12-20
Granted: 1999-10-21
Abstract: A fuel additive composition comprising: (a) a poly(oxyalkylene) hydroxyaromatic ester having the formula:   <IMAGE>    or a fuel-soluble salt thereof; where R1 and R2 are each independently hydrogen, hydroxy, lower alkyl having 1 to 6 carbon atoms, or lower alkoxy having 1 to 6 carbon atoms; R3 and R4 are each independently hydrogen or lower alkyl having 1 to 6 carbon atoms; R5 is hydrogen, alkyl having 1 to 30 carbon atoms, phenyl, aralkyl or alkaryl having 7 to 36 carbon atoms, or an acyl group having the formula:   <IMAGE>    where R6 is alkyl having 1 to 30 carbon atoms, phenyl, or aralkyl or alkaryl having 7 to 36 carbon atoms; R7and R8 are each independently hydrogen, hydroxy, lower alkyl having 1 to 6 carbon atoms, or lower alkoxy having 1 to 6 carbon atoms; n is an integer from 5 to 100; and x and y are each independently an integer from 0 to 10; and (b) an aliphatic amine having at least one basic nitrogen atom and containing a hydrocarbyl group which has sufficient molecular weight and carbon chain length to render the aliphatic amine soluble in hydrocarbons boiling in the gasoline or diesel fuel range.
Patent DE-69332105-D1 (DE)
Inventor: PATTON JOHN S
IPC: A61P43/00
Filed: 1993-09-29
Granted: 2002-08-14
Abstract: Systemic delivery of parathyroid hormone to a mammalian host is accomplished by inhalation through the mouth of a dispersion of an N-terminal fragment of PTH. It has been found that such respiratory delivery of the PTH fragment provides a pulsatile concentration profile of the PTH in the host's serum. PTH fragment compositions include dry powder formulations having the PTH present in a dry bulking powder, liquid solutions or suspensions suitable for nebulization, and aerosol propellants suitable for use in a metered dose inhaler.
Patent DE-69402297-D1 (DE)
Inventor: MASSON GERARD
IPC: A61K8/00
Filed: 1994-12-07
Granted: 1997-04-30
Abstract: Cosmetic or dermatological compsn. is a powder, obtd. from an oil-in-water emulsion by homogenisation and dehydration. The emulsion contains a structural and emulsifying agent, at least one fatty material, at least one cosmetic or dermatologically active agent and an aq. phase. The powder is capable of being reconstituted, by hydration, to the emulsion.
Patent DE-69415531-D1 (DE)
Inventor: INGERSOLL CLYDE E
IPC: A44C27/00
Filed: 1994-10-24
Granted: 1999-02-04
Abstract: A process for making metal castings, comprising the steps of     (a) preparing an alloy from at least two different metals;   (b) forming the alloy into a powder;   (c) optionally combining the powder with a lubricant and/or flux;   (d) pressing the powder into pellets;   (e) melting one or more of the pellets;   (f) casting the molten alloy into the mold;   (g) cooling the metal casting.   This process allows for the production of alloy castings even from high melting poorly soluble metals. The use of pellets containing a lubricant and/or flux is preferred. In addition the pellets may contain deoxidizers, grain refiners, and/or oxidizers. The process is especially suitable for the manufacture of dental, jewelry and precision castings.
Patent DE-69419394-D1 (DE)
Inventor: MOIREAU PATRICK
IPC: C03C25/26
Filed: 1994-12-06
Granted: 1999-08-12
Abstract: Process for the manufacture of continuous glass filaments. The process consists in depositing on the glass filaments being drawn a size consisting of a solution whose solvent content is lower than 5 % by weight, the said solution including a mixture of components that are polymerisable and/or crosslinkable by heat treatment, the said components being, in the case of at least 60 % by weight thereof, components whose molecular mass is lower than 750, less than 10 % by weight of film-forming agents and from 0 to 25 % by weight of bridging agents, lubricating agents, stabilising agents and initiators and/or catalysts, the said agents being optionally polymerisable and/or crosslinkable by heat treatment, in reeling the filament(s) formed by bringing together the said filaments onto a rotating support to form a winding consisting of turns of filament coated with an unpolymerised size. The filaments are intended for the reinforcement of thermoplastic or heat-curable organic substances or of substances of inorganic origin.
Patent DE-69420037-D1 (DE)
Inventor: SELLARS ALAN
IPC: D02G1/12
Filed: 1994-05-20
Granted: 1999-09-16
Abstract: Staple fibres of solvent-spun cellulose are made by a method in which: i) cellulose is dissolved in an amine oxide solvent to form a hot cellulose solution, ii) the hot cellulose solution is extruded through a die assembly to form a tow of continuous filaments, iii) the tow is passed through a water bath to leach out the amine oxide, iv) the tow is crimped by passing through a stuffer box in which it is compressed to apply crimp, v) dry steam being injected into the stuffer box during the crimping process, and vi) the crimped tow is passed to a cutter and cut to the desired fibre length. An apparatus is also provided in which the staple fibres can be made.
Patent DE-69421693-D1 (DE)
Inventor: HILL JEFFREY
IPC: G06K5/02
Filed: 1994-02-17
Granted: 1999-12-23
Abstract: An embossed card pack production system (10) having a microprocessor based computer (12) for controlling an embosser (20) for embossing characters on a credit card (30) and magnetically encoding information on a magnetic stripe (35) of the card (30), a card labeler (60) for placing releasable informational labels on the embossed cards (30), a forms reader (38) for reading printed code information from a card carrier form (26), a card inserter (24) connected with the card embosser (20) for mounting cards (30) having card information matching with the coded carrier information to corresponding carrier forms (26), a carrier form folder (86), an envelope stuffer (34) for placing the folded carrier into envelopes and a postage metering machine (18) connected to the envelope stuffer (34).
Patent DE-69426157-D1 (DE)
Inventor: KAWASHIMA YOICHI
IPC: C07D295/096
Filed: 1994-07-25
Granted: 2000-11-23
Abstract: A novel compound represented by general formula ÄIÜ, wherein R<1> and R<2> may be the same or different from each other and each represents lower alkoxy; and A and B may be the same or different from each other and each represents lower alkylene. It has a  sigma  receptor affinity and is useful as a remedy for diseases accompanying cranial nerve function disorder, such as dementia, depression, schizophrenia and anxiety, immunopathy and cryptorrhea, and digestive ulcer. <CHEM>
Patent DE-69430005-D1 (DE)
Inventor: BRIGGS E
IPC: C12N15/10
Filed: 1994-12-06
Granted: 2002-04-04
Abstract: Methylation of DNA can be a critical step in the introduction of DNA into P. haemolytica. A methyltransferase has been isolated and molecularly cloned for this purpose. Use of the methyltransferase has allowed construction of defined, attenuated aroA mutants for use as vaccines to protect cattle.
Patent DE-69430488-D1 (DE)
Inventor: YAPP G
IPC: F04D29/54
Filed: 1994-08-30
Granted: 2002-05-29
Abstract: Stationary flow control vanes (28) positioned to encounter and redirect recirculating airflow provide a surprising combination of efficiency, low noise, and manufacturability for shrouded, banded, axial fans (20) that are positioned in a housing (26). Such fan and housing combinations reduce swirl in recirculating airflow, so that the airflow entering the fan (which includes the recirculating airflow) is more ordered and fan performance is improved. It can also be applied to fans that blow air through a downstream heat exchanger (21). The invention is also suited for ducted fans.
Patent DE-69430999-D1 (DE)
Inventor: SANOU YOSHIHISA
IPC: G09G3/22
Filed: 1994-12-20
Granted: 2002-08-22
Abstract: An image-forming apparatus including an electron beam source comprising a plurality of electron-emitting devices on a substrate, each electron-emitting device comprising a negative electrode, an electron-emitting region and a positive electrode which are arranged on the surface of said substrate side by side in a direction parallel to a common direction;   image-forming members for forming an image upon irradiation of electron beams emitted from said electron-emitting devices; drive means for applying drive signals to said plurality of electron-emitting devices in accordance with image signals; and   voltage means for applying a voltage to said image-forming members,     characterised by shifting means to shift an array sequence order of the image signals in accordance with a positional deviation from a set value for the relative position between said electron-emitting devices and said image-forming members.
Patent DE-69500948-D1 (DE)
Inventor: BLIZZARD JOHN DONALD
IPC: C09D167/07
Filed: 1995-02-06
Granted: 1997-12-04
Abstract: Radiation-curable oligomer-based compositions for forming an abrasion-resistant coating on a substrate are formulated from a Michael adduct and colloidal silica. The Michael adduct includes a multifunctional acrylate oligomer and an aminoalkoxysilane. The multifunctional acrylate oligomer is present in at least a two-to-one, and preferably a ten-to-one, Michael adduct equivalency. The cured coating compositions of the invention are adherent to numerous substrates and exhibit excellent adhesion, stain and abrasion resistance. The coating compositions of the invention have the advantage of relatively low silica solids loading and can avoid the use of toxic, low molecular weight multifunctional acrylate monomers.
Patent DE-69504447-D1 (DE)
Inventor: DECLERCQ PHILIPPE
IPC: B65G51/03
Filed: 1995-10-06
Granted: 1998-10-08
Abstract: The conveyor has a guide channel (6,7) to support the bottles by their necks while they are moved by air jets. The conveyor has two side panels (9), one on each side of the guide channel, to contain the injected air flows, and deflectors (12) which run the length of the conveyor and are inclined to form passages which diverge towards the top between deflectors and side panels. The air used by the conveyor is injected from a housing (4) which has an inner recess formed by the guide channel, and apertures (8,10) to guide the air from the housing into the channel and the air flow passages.
Patent DE-69523148-D1 (DE)
Inventor: TANIBUCHI YUJI
IPC: H01M10/34
Filed: 1995-11-06
Granted: 2001-11-15
Abstract: An AB5 type age-precipitating rare earth metal-nickel alloy having a composition expressed by (1): R(Ni1-xMx)5+y where R represents one or more of rare-earth elements including Y, M represents one or more selected from a group of Co, Al, Mn, Fe, Cu, Zr, Ti, Mo, W, and B and x and y respectively satisfy the relations 0.05 </= x </= 0.5 and -0.45 </= y </= 0.45. The alloy has a precipitated phase of 0.1-20 mu m in average major axis. A raw alloy material having the composition expressed by formula (1) is subjected to a solid solution treatment at above 1000  DEG C, and aged for a period of time t which satisfies the relation (2): (830-T)/200 </= log t </= (1,200-T)/200 at a temperature T ( DEG C) of >/= 700  DEG C and < 1,000  DEG C so as to produce the precipitated phase having an average major axis of 0.1-20  mu m. <IMAGE>
Patent DE-69528638-D1 (DE)
Title: Yacht
Inventor: EVERETT PETER KENNETH
IPC: B63H9/06
Filed: 1995-03-17
Granted: 2002-11-28
Abstract: PCT No. PCT/AU95/00143 Sec. 371 Date Dec. 16, 1996 Sec. 102(e) Date Dec. 16, 1996 PCT Filed Mar. 17, 1995 PCT Pub. No. WO95/25663 PCT Pub. Date Sep. 28, 1995A yacht (10) includes a mast (12) that is mechanically connected to a keel (14) via a bearing (16), located in the base of hull (18) of the yacht (10). A sail foil (30) is pivotally mounted to the top of the mast (12) via a rotating bearing (34). In use, as the wind forces the sail foil (30) and mast (12) to leeward, a corresponding movement to windward is induced in the keel (14) and thus the yacht's hull (18) can remain substantially horizontal with respect to surrounding flat water.
Patent DE-69529682-D1 (DE)
Inventor: SMITH RICHARD G
IPC: A61H9/00
Filed: 1995-11-07
Granted: 2003-03-27
Abstract: An open angle glaucoma treatment method and apparatus wherein pressure, positive or negative, is applied to the frontal surface of the eye. The open angle glaucoma treatment apparatus is a vacuum source and a vacuum applicator coupled by a hose. The vacuum applicator is an eye ring or an eye cup that is placed on the frontal surface of an eye. Suction (negative pressure) in the range of 10 to 30 mm. Hg. is applied by the vacuum source, which will fixate the ring or cup to the eye, or alternatively pressure is applied via ring or cup that is held in place. The suction or pressure is applied for 15 to 120 seconds. A second treatment is recommended later. It could be within twelve hours, on the following day, or within the next couple of days. A second treatment more than five days later considered less effective or ineffective.
Patent DE-69532468-D1 (DE)
Inventor: FERGES JOHNNES
IPC: C10J3/84
Filed: 1995-03-08
Granted: 2004-02-26
Abstract: Disclosed is a gas conditioner and a method for treating crude, relatively impure gases produced from a gasification process to yield a relatively clean, tar-free producer gas having an energy value of about 1200 to 1500 Kcal/m3. The gas conditioner comprises a reaction chamber for retaining a fuel supply and containing a cracking reaction. An upper portion of the reaction chamber includes an internal reaction housing which provides a primary reaction zone. The gas conditioner also includes a grate structure for filtering producer gas prior to its exit from the conditioner.
Patent DE-69533239-D1 (DE)
Inventor: CORLESS MARIE
IPC: A61K47/34
Filed: 1995-04-19
Granted: 2004-08-12
Abstract: The present invention relates to anti-acne compositions having good efficacy, low skin irritation, and good physical and chemical stability. These compositions comprise a benzoyl peroxide, a wetting agent, water, a non-volatile emollient component which is a liquid at 25 DEG  C. and which has a weighted arithmetic mean solubility parameter of less than or equal to about 7, and a water soluble or dispersible gelling agent.
Patent DE-69535035-D1 (DE)
Inventor: CARRANO RICHARD A
IPC: C12N15/00
Filed: 1995-03-30
Granted: 2006-07-20
Abstract: Methods of introducing genetic material into cells of an individual and compositions and kits for practising the same are disclosed. The methods comprise the steps of contacting cells of an individual with a genetic vaccine facilitator and administering to the cells a nucleic acid molecule that is free of retroviral particles. The nucleic acid molecule comprises a nucleotide sequence that encodes a protein that comprises at least one epitope that is identical or substantially similar to an epitope of a pathogen antigen or antigen associated with a hyperproliferative or autoimmune disease, a protein otherwise missing from the individual due to a missing, non-functional or partially functioning gene, or a protein that produces a therapeutic effect on an individual. Methods of prophylactically and therapeutically immunizing an individual against HIV are disclosed. Pharmaceutical compositions and kits for practising methods of the present invention are disclosed.
Patent DE-69604049-D1 (DE)
Inventor: TSENG CHENG-TZU
IPC: A47G19/03
Filed: 1996-04-11
Granted: 1999-10-07
Abstract: An assembly for treating food comprising a bottom disc (1) having a plain surface (11) and a plurality of interchangeable disc-like plates (2), wherein a planar surface (11) of the bottom disc (1) is provided with a plurality of annular grooves (111) and radiant grooves (112), and the bottom of each plate (2) has a recess (21) which is conformed in shape for receiving the bottom disc (1). By means of such assembly, frozen food can be defrosted and treated more conveniently and sanitarily. <IMAGE>
Patent DE-69608531-D1 (DE)
Inventor: BOUTET ROBERT-LOUIS
IPC: A61B17/88
Filed: 1996-12-20
Granted: 2000-06-29
Abstract: The strap consists of a flat strip (1) fixed at one end to a clasp (2) and having a needle on its other end. The clasp has a rectangular section channel through it between lower (5) and upper (6) walls, and the upper wall is cut out to form vertical lugs (3) which can be bent over on top of the strip. The strip is fastened to the clasp by being passed round it in at least one turn, forming at least one outer layer and two inner layers, and leaving sufficient space in the channel for the free end of the strip to be passed through after the needle has been removed. The strap can be tensioned by a clamp with a sloping surface and lever before fixing. Both strip and clasp are made from a biocompatible material such as stainless steel.
Patent DE-69612574-D1 (DE)
Inventor: PERMINGEAT VINCENT
IPC: B42D25/30
Filed: 1996-08-05
Granted: 2001-05-23
Abstract: An improvement to a method for making cards with an electronic module is disclosed. The method comprises the steps of providing a card body (1) having a cavity (3, 4), an electronic module (5I) shaped to fit said cavity, and at least one first adhesion means (12c-15c) adherable to the card body and the module, depositing at least said first adhesion means in said cavity, inserting said module into the cavity in a substantially centered position, and pressing at least said first adhesion means between the card and the module. The method further comprises a step of providing a second adhesion means (11b) which is also deposited in the cavity (3, 4). said second adhesion means is capable of having sufficient tackiness to maintain the module (5) in a centered position in the cavity, at least until said first adhesion means has been pressed. The cards produced by carrying out the method are also disclosed.
Patent DE-69622006-D1 (DE)
Inventor: TAKECHI NOBUYUKI
IPC: A61K9/16
Filed: 1996-12-13
Granted: 2002-08-01
Abstract: Disclosed is a sustained-release microsphere comprising a physiologically active substance and a biodegradable polymer, which is obtainable from a process which comprises subjecting a w/o/w emulsion or o/w emulsion, wherein said physiologically active substance is in an inner aqueous phase and said biodegradable polymer is in an external oil phase, to an in-water drying method under the following conditions:   1) the amount of microspheres per m<3> of an external aqueous phase is about 0.1 to about 500 kg, 2) the square root of the area (unit: m<2>) of the liquid surface in contact with the gas phase is about 0.2 to about 4.5 per the cube root of the volume (unit: m<3>) of an external aqueous phase, 3) the w/o/w emulsion or o/w emulsion is replaced at the replacement frequency of about 0.01 to about 10 times/minutes, 4) a gas is blown to the w/o/w emulsion or o/w emulsion at the gas transfer rate near the liquid surface of about 0.1 to about 300 m/second, and 5) the gas is replaced at the replacement frequency of not less than about 0.5 times/minutes.   The method described increases the rate of solvent removal from microspheres in in-water drying, reducing the amount of solvent in microspheres in a short time.
Patent DE-69626829-D1 (DE)
Inventor: CURIN SERBEC VLADKA
IPC: C07K16/18
Filed: 1996-07-31
Granted: 2003-04-24
Abstract: The present invention belongs to the field of pharmaceutical industry and relates to novel monoclonal antibodies and fragments thereof which are bound to the available surface of a human recombinant TNF- alpha , TNF- alpha  analogues and TNF- alpha  soluble receptors p55 and p75. Further, the invention relates to stable hybridoma cell lines, which lines are capable of producing such monoclonal antibodies, to a process for the preparation thereof and to pharmaceutical preparations containing them. The invention also relates to a method for the quantitative determination of human TNF- alpha , free or complexed with soluble TNF- alpha  receptors p55 and p75, and to a kit used therefor. By hitherto disclosed monoclonal antibodies and reagents developed therefrom, it has not been possible to simultaneously determine free TNF- alpha  and its soluble receptors p55 and p75 as well as complexes thereof. Another object of the invention is also the TNF- alpha  analogue TNF- alpha  Cys95His107His108Cys148, which in a complex with TNF- alpha  soluble receptors, is used as an antigen for immunization of mice.
Patent DE-69627193-D1 (DE)
Inventor: CANAN-KOCH STACIE
IPC: C07C59/72
Filed: 1996-09-17
Granted: 2003-05-08
Abstract: Dimer-selective RXR modulator compounds having agonist, partial agonist and/or antagonist activity in the context of an RXR homodimer and/or RXR heterodimers are provided. Also provided are pharmaceutical compositions incorporating such dimer-selective RXR modulator compounds and methods for their therapeutic use. <IMAGE> <IMAGE> <IMAGE>
Patent DE-69628025-D1 (DE)
Inventor: KADDURAH-DAOUK RIMA
IPC: G06G7/48
Filed: 1996-10-11
Granted: 2003-06-12
Abstract: The present invention relates to the use of creatine compounds including cyclocreatine and creatine phosphate for treating or preventing a metabolic disorder consisting of hyperglycemia, insulin dependent diabetes mellitus, impaired glucose tolerance, hyperinsulinemia, insulin insensitivity, diabetes related diseases in a patient experiencing said disorder. The creatine compounds which can be used in the present method include (1) analogues of creatine which can act as substrates or substrate analogues for the enzyme creatine kinase; (2) compounds which can act as activators or inhibitors of creatine kinase; (3) compounds which can modulate the creatine transporter (4) N-phosphocreatine analogues bearing transferable or non-transferable moieties which mimic the N-phosphoryl group. (5) compounds which modify the association of creatine kinase with other cellular components.
Patent DE-69637553-D1 (DE)
Inventor: HENNING TIMOTHY P
IPC: G01N27/28
Filed: 1996-11-26
Granted: 2008-07-10
Abstract: The present invention relates to a device (10) for the sampling of blood or other body fluids which includes means (16) for the direct measurement of the analyte of interest within the fluid. Also disclosed is a "closed-loop" device and method wherein the analyte is measured and the required amount of drug is determined and injected, without removal of the device from the patient's body. <IMAGE>